PR Newswire updates

09.21
2026
Randstad Malaysia scales operations amid strong growth in permanent and flexible talent solutions
09.21
2026
Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia
09.20
2026
Global Times: How Mohe, China's northernmost and coldest city, turns ice and snow into invaluable assets

Who Wins and Who Loses in This Changing Landscape
December 23, 2024
Leferi Shines a Light on K-Beauty with Successful 'KYEA' Awards… Overall Top Honors Go to numbuzin and CLIO
December 23, 2024
Inspur Smart Healthcare Participates in GITEX IMPACT 2024 Exhibition
December 23, 2024
Kickstart 2025 with Expert Holiday Health Tips
December 23, 2024
Siraj Finance PJSC signs an agreement with Azentio for iMAL core and digital financial services solution subscription optimization
December 23, 2024
New Report: What rises in the East and goes down in the West? Ambition to lead
December 23, 2024
GDIN Support Strengthens South Korea's Digital Twin Industry
December 23, 2024
Don't miss 2024 Seoul Lantern Festival and 2024 Gwanghwamun Market this Christmas
December 23, 2024

Randstad Malaysia scales operations amid strong growth in permanent and flexible talent solutions

Randstad Malaysia scales operations amid strong growth in permanent and flexible talent solutions

KUALA LUMPUR, Malaysia, Sept. 21, 2026 /PRNewswire/ — Randstad Malaysia, the…

Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia

SINGAPORE, Sept. 21, 2026 /PRNewswire/ — Independent biopharmaceutical…

Global Times: How Mohe, China's northernmost and coldest city, turns ice and snow into invaluable assets

BEIJING, Sept. 20, 2026 /PRNewswire/ — At 53 degrees north latitude, Mohe…

JACC: Clinical Electrophysiology Publishes 12-Month Outcomes from Field Medical's First-in-Human Field PULSE Trial: 94.2% Per-Vein PVI Durability with Optimized Waveform

JACC: Clinical Electrophysiology Publishes 12-Month Outcomes from Field Medical's First-in-Human Field PULSE Trial: 94.2% Per-Vein PVI Durability with Optimized Waveform

Late-breaking HRX data advance Field Medical’s "instantaneous ablation"…